Endocrine Reviews
Obesity science, research gaps, and opportunities in the new era of obesity medicines: an Endocrine Society scientific statement
ReviewInterventions
The paper
Yale University; Mount Sinai Hospital
Endocrine Reviews, 9 Sep 2026
Related
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes